ANDA 62507, held by Solopak. Gentamicin Sulfate.
As of Nov 15, 2026, ANDA 62507 (Gentamicin Sulfate), held by Solopak, was not approved, with 0 approved supplements and 0 published complete response letters.
| Gentamicin SulfateEQ 10MG BASE/ML · injectable;injection | Gentamicin Sulfate | Discontinued |
| Gentamicin SulfateEQ 40MG BASE/ML · injectable;injection | Gentamicin Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
